Castleview Partners’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-49
Closed -$2.15K 922
2024
Q2
$2.15K Hold
49
﹤0.01% 730
2024
Q1
$2.56K Hold
49
﹤0.01% 720
2023
Q4
$3.06K Sell
49
-1,804
-97% -$146K ﹤0.01% 653
2023
Q3
$173K Buy
1,853
+111
+6% +$10.4K 0.16% 127
2023
Q2
$174K Buy
1,742
+229
+15% +$32.3K 0.16% 128
2023
Q1
$272K Buy
1,513
+1,509
+37,725% +$292K 0.24% 98
2022
Q4
$833 Hold
4
﹤0.01% 565
2022
Q3
$1K Sell
4
-2,815
-100% -$932K ﹤0.01% 602
2022
Q2
$420K Buy
2,819
+428
+18% +$169K 0.33% 68
2022
Q1
$983K Sell
2,391
-54,036
-96% -$19.9M 0.61% 23
2021
Q4
$48.7K Buy
+56,427
New +$20M 0.39% 27
2021
Q2
$208K Buy
+441
New +$263K 0.09% 211

Other funds holding VXX

Castleview Partners's VXX Position: Q3 2024 in Review

Castleview Partners sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q3 2024, closing a stake of 49 shares — an estimated $2.15K sold.

Castleview Partners first reported a position in VXX in Q2 2021 and held it in 12 quarters. The position peaked at $983K in Q1 2022. 54 funds tracked by Wall St. Rank hold VXX as of Q3 2024.

  • Castleview Partners reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 49 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q3 2024, an estimated $2.15K.
  • Castleview Partners first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2021 and held it in 12 quarters.
  • Castleview Partners's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $983K in Q1 2022.
  • 54 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.